Munoz, M. (2026). Aprepitant, When Used with Chemotherapy, Reduces the Risk of Recurrence, Metastasis, And Mortality in Patients with Breast Cancer: Aprepitant in Breast Cancer Outcomes. Pakistan Journal of Health Sciences, 7(8), 01–02. https://doi.org/10.54393/pjhs.v7i8.4537